Across TCGA pan-cancer cohorts, LINC01567 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of LINC01567’s most consistent transcriptional readouts.
The strongest signal is observed in lung squamous cell carcinoma (LUSC), where LINC01567 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01567 is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.
LUSC, BRCA, and LUAD are the cancer types where LINC01567 tumor–normal differential expression is most reproducible.